Brief: Corona Remedies Commences Additional Production At Bhayla Facility
22/12/2025 09:46
Dec 22 (Reuters) - Corona Remedies Ltd CORD.NS: COMMENCES ADDITIONAL PRODUCTION AT BHAYLA FACILITY ADDITIONAL PRODUCTION RAISES CAPACITY BY 400 MILLION Source text: ID:nNSE4BZGMB Further company coverage: CORD.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Corona Remedies
See all newsBrief: Corona Remedies Gets GMP Compliance Certification From Brazilian Health Regulatory Agency
Brief: Corona Remedies June-Quarter Consol Net Profit 601.1 Million Rupees
India's CORONA Remedies rises after block deal
Brief: Corona Remedies March-Quarter Consol Net Profit 453.3 Million Rupees
Brief: Corona Remedies Ltd Announces Strategic Acquisition Of Wokadine In India